Taysha Gene Therapies
Latest funding:$200.0M · Post-IPO Equity (June 24, 2026)
Angel investors who backed Taysha Gene Therapies
23 investors in our database backed Taysha Gene Therapies.
Krishna Yeshwant
Attending
Karim Faris
General Partner
Blake Byers
General Partner
Jason Mehring
Managing Director
Laurence Paredes
Private Debt Product Structuring & Fund Board Engagement Lead / Global Private Debt
Jim Keenan
MD
Daniel Nellis
Director - US Private Capital
Rob DiPaolo
Managing Director
Michael Pungello
Interim CFO and Treasurer
R. Marshall Merriman
Managing Director
Nik Singhal
Managing Director
Andrew Norman
Vice President
Michael Leitner
Managing Director
Eli Casdin
Chief Investment Officer
Paul Manning
President
Jayson Rieger
SVP Business Development & Portfolio Management
Gene Scavola
Managing Partner
Rusty Schundler
Corporate Counsel
Sung You
Partner
Rob Weitz
Managing Director
Jake Ksendzov
Associate
Paras Mehta
CIO
Peter Nolan
Chairman
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Taysha Gene Therapies.
Search investors